Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis

Antiresorptive agents are widely used to treat osteoporosis. Both reduction in bone turnover and increase in BMD may be necessary to decrease the fracture risk. The aim of the study was to evaluate the effects of aledronate on bone turnover markers and bone mineral density in postmenopausal women wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bosn J Basic Med Sci
Hlavní autoři: Kučukalić-Selimović, Elma, Valjevac, Amina, Hadžović-Džuvo, Almira, Skopljak-Beganović, Amra, Alimanovic-Alagić, Rubina, Brković, Amera
Médium: Artigo
Jazyk:Inglês
Vydáno: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362565/
https://ncbi.nlm.nih.gov/pubmed/21342141
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky